Lord, Abbett & Co’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-533,599
Closed -$6.42M 535
2025
Q1
$6.42M Buy
533,599
+35,750
+7% +$468K 0.02% 433
2024
Q4
$5.5M Sell
497,849
-497,600
-50% -$7M 0.02% 459
2024
Q3
$16.1M Buy
995,449
+188,685
+23% +$2.64M 0.05% 353
2024
Q2
$8.75M Sell
806,764
-23,768
-3% -$292K 0.03% 404
2024
Q1
$11.6M Buy
+830,532
New +$10.8M 0.04% 384

Other funds holding EOLS

Lord, Abbett & Co's EOLS Position: Q2 2025 in Review

Lord, Abbett & Co sold out of Evolus (EOLS) in Q2 2025, closing a stake of 533,599 shares — an estimated $6.42M sold.

Lord, Abbett & Co first reported a position in EOLS in Q1 2024 and held it in 5 quarters. The position peaked at $16.1M in Q3 2024. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Lord, Abbett & Co reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 533,599 Evolus shares in Q2 2025, an estimated $6.42M.
  • Lord, Abbett & Co first reported a position in Evolus in Q1 2024 and held it in 5 quarters.
  • Lord, Abbett & Co's Evolus position peaked at $16.1M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Lord, Abbett & Co's 13F filing for Q2 2025, filed 14 Aug 2025.